Published in Clin Transpl on January 01, 1993
Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut (1999) 2.98
Current concepts in transplant surgery: liver transplantation today. Langenbecks Arch Surg (2008) 0.96
Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95
Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53
Quasars revisited: rapid time variations observed via very-long-baseline interferometry. Science (1971) 3.97
Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group. N Engl J Med (1998) 3.76
Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet (1981) 3.38
Cyclosporin A and steroid therapy in sixty-six cadaver kidney recipients. Surg Gynecol Obstet (1981) 2.92
Euthanasia by stages. Lancet (1996) 2.86
Reasons for possible failure of inoculation to enhance biodegradation. Appl Environ Microbiol (1985) 2.82
Immunosuppression, generic drugs and the FDA. Am J Transplant (2011) 2.43
Reduced food intake after jejunoileal bypass: a possible association with prolonged gastric emptying and altered gut hormone patterns. Am J Clin Nutr (1997) 2.27
Antigen-presenting capabilities of human monocytes correlates with their expression of HLA-DS, an Ia determinant distinct from HLA-DR. J Immunol (1983) 2.25
Shipment of human islets for transplantation. Am J Transplant (2007) 2.01
American Society of Transplant Surgeons transplant center outcomes requirements--a threat to innovation. Am J Transplant (2009) 2.00
Efficiency of liver transplantation in patients with primary biliary cirrhosis. N Engl J Med (1989) 1.94
Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: a pilot study in 20 patients. Gastroenterology (1993) 1.90
Total hepatectomy and liver replacement (orthotopic liver transplantation) for primary hepatic malignancy. World J Surg (1982) 1.84
Proceedings of Consensus Conference on Simultaneous Liver Kidney Transplantation (SLK). Am J Transplant (2008) 1.81
FK506 trough levels in whole blood and plasma in liver transplant recipients. Correlation with clinical events and side effects. Transplantation (1994) 1.80
End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment. Transplantation (2001) 1.79
Swedish obese subjects (SOS)--an intervention study of obesity. Baseline evaluation of health and psychosocial functioning in the first 1743 subjects examined. Int J Obes Relat Metab Disord (1993) 1.75
HLA compatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching. Transplantation (1994) 1.71
Impact of pretransplant renal function on survival after liver transplantation. Transplantation (1995) 1.58
Limiting hepatitis C virus progression in liver transplant recipients using sirolimus-based immunosuppression. Am J Transplant (2011) 1.56
Swedish obese subjects (SOS). Recruitment for an intervention study and a selected description of the obese state. Int J Obes Relat Metab Disord (1992) 1.55
Readmission to the intensive care unit after liver transplantation. Crit Care Med (2001) 1.54
Metallic stents for the treatment of intrahepatic biliary strictures after liver transplantation. J Vasc Interv Radiol (1996) 1.51
One-year results with extended-release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/MMF in de novo kidney transplant recipients. Am J Transplant (2007) 1.51
Impact of IgG3 subclass and C1q-fixing donor-specific HLA alloantibodies on rejection and survival in liver transplantation. Am J Transplant (2015) 1.50
Belatacept-based immunosuppression in de novo liver transplant recipients: 1-year experience from a phase II randomized study. Am J Transplant (2014) 1.50
Liver transplantation for metastatic neuroendocrine tumor disease. Transplant Proc (2003) 1.47
Optimal timing of liver transplantation for primary biliary cirrhosis. Hepatology (1998) 1.46
De novo hepatitis B infection after liver transplantation: source of disease, incidence, and impact. Liver Transpl Surg (1998) 1.42
The use of marginal donors for liver transplantation. A retrospective study of 365 liver donors. Transplantation (1992) 1.41
Effect of pentoxifylline on hepatic ischemia and reperfusion injury. Surgery (1997) 1.41
Cryptococcosis after renal transplantation: report of ten cases. Surgery (1976) 1.41
Radar Observations of Jupiter quency shift which observed. Science (1964) 1.39
Cyclosporin A hepatotoxicity in 66 renal allograft recipients. Transplantation (1981) 1.38
The influence of preservation injury on rejection in the hepatic transplant recipient. Transplantation (1990) 1.37
Surgical treatment of diabetic nephropathy with simultaneous pancreatic duodenal and renal transplantation. Surg Gynecol Obstet (1986) 1.35
Pharmacokinetics of tacrolimus in liver transplant patients. Clin Pharmacol Ther (1995) 1.33
Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity. Int J Obes Relat Metab Disord (1997) 1.33
High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection Postliver transplant. Am J Transplant (2011) 1.29
Eosinopenia of acute infection: Production of eosinopenia by chemotactic factors of acute inflammation. J Clin Invest (1980) 1.24
Importance of small bowel peptides for the improved glucose metabolism 20 years after jejunoileal bypass for obesity. Obes Surg (1998) 1.20
Is liver transplantation indicated for cholangiocarcinoma? Am J Surg (1993) 1.20
All human monocytes have the capability of expressing HLA-DQ and HLA-DP molecules upon stimulation with interferon-gamma. J Immunol (1986) 1.19
Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome--experience in 300 patients. Transplantation (1991) 1.18
A decade followup in early cases of renal homotransplantation. Ann Surg (1974) 1.16
Renal replacement therapy and orthotopic liver transplantation: the role of continuous veno-venous hemodialysis. Transplantation (2001) 1.15
The elderly liver transplant recipient: a call for caution. Ann Surg (2001) 1.15
Differential expression of Ia molecules by human monocytes. J Clin Invest (1984) 1.15
Results after liver retransplantation (RETx): a comparative study between "elective" vs "nonelective" RETx. Transplant Proc (1990) 1.14
Alpha fetoprotein, ultrasound, computerized tomography and magnetic resonance imaging for detection of hepatocellular carcinoma in patients with advanced cirrhosis. Aliment Pharmacol Ther (2007) 1.13
Liver transplant in complete situs inversus: a case report. Surgery (1993) 1.12
Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine. Scand J Gastroenterol (1991) 1.12
Problematic vascular reconstruction in liver transplantation. Part I. Arterial. Surgery (1990) 1.12
RS-61443 (mycophenolate mofetil). A multicenter study for refractory kidney transplant rejection. Ann Surg (1992) 1.11
Liver allotransplantation after extracorporeal hepatic support with transgenic (hCD55/hCD59) porcine livers: clinical results and lack of pig-to-human transmission of the porcine endogenous retrovirus. Transplantation (2000) 1.10
Ten years of liver transplantation: an evolving understanding of late graft loss. Transplantation (1997) 1.10
Hepatic artery stenosis after liver transplantation--incidence, presentation, treatment, and long term outcome. Transplantation (1997) 1.09
The impact of operative bleeding on outcome in transplantation of the liver. Surg Gynecol Obstet (1993) 1.08